Drug intelligence / Profile preview

Jiawei Xiaolong pill

Development stage
Unknown
Lead developer
Kaken Pharmaceutical
Administration
Oral
01

Overview

Jiawei Xiaolong pill is a traditional Chinese medicine (TCM) formulation developed by Longhua Hospital affiliated with the Shanghai University of Traditional Chinese Medicine in collaboration with the Shanghai Shenkang Hospital Development Center. It is administered orally and is currently being investigated for its potential to reduce the risk of malignancy in patients with residual lung ground glass nodules (GGN). The therapeutic approach is based on TCM principles, often involving the regulation of 'Qi' and the resolution of phlegm or stasis, though specific molecular targets have not been publicly characterized. The clinical evaluation of this drug incorporates AI image judgment technology to monitor changes in nodule characteristics and assess the risk of malignant transformation.

Other names
Jiawei Xiaolong Wan加味小龙丸

Beyond the preview

Go deeper on Jiawei Xiaolong pill.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiawei Xiaolong pill.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call